![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 52, 50487-50490, December 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and
From the § Medical Research Council Radiation and Genome
Stability Unit, Harwell, Oxfordshire, OX11 0RD, United Kingdom and
Cancer Research UK, Carcinogenesis Group, Paterson
Institute for Cancer Research, Christie Hospital National Health
Service Trust, Manchester, M20 4BX, United Kingdom
Received for publication, August 9, 2002
| |
ABSTRACT |
|---|
|
|
|---|
In mammalian cells, thymine glycols and other
oxidized pyrimidines such as 5,6-dihydrouracil are removed from DNA by
the NTH1 protein, a bifunctional DNA-N-glycosylase.
However, mNTH1 knock-out mice in common with other DNA
glycosylase-deficient mice do not show any severe abnormalities
associated with accumulation of DNA damage and mutations. In the
present study we used an in vitro repair system to
investigate the mechanism for the removal of 5,6-dihydrouracil
from DNA by mNTH1-deficient cell-free extracts derived from testes of
mNTH1 knock-out mice. We found that these extracts are able to support
the removal of 5,6-dihydrouracil from DNA at about 20% of the
efficiency of normal extracts. Furthermore, we also found that
single-nucleotide patch base excision repair is the major pathway for
removal of 5,6-dihydrouracil in mNTH1-deficient cell extracts,
suggesting the involvement of other DNA glycosylase(s) in the removal
of oxidized pyrimidines.
Reactive oxygen species generate a multitude of different damage
to the DNA molecule. In addition to highly cytotoxic double strand
breaks, over 20 different types of base damage have been identified in
DNA (1). To combat this potentially mutagenic and toxic damage, cells
have developed a number of DNA glycosylases that recognize specific
types of chemically altered bases and remove them from the DNA in the
first step of base excision repair (BER).1 In mammalian cells,
the NTH1 protein, a functional and structural homolog of
Escherichia coli endonuclease III, removes oxidized pyrimidines (2, 3). In common with endonuclease III, mNTH1 has a
broad substrate specificity, releasing among others thymine glycol,
5,6-dihydrouracil, 5-hydroxycytosine, and urea residues (4).
Recently we reported the generation of a strain of mice deleted in
mNTH1 (5). mNTH1 knock-out mice are viable and outwardly normal and
show no evident deleterious effects of the glycosylase deletion despite
the known mutagenic and toxic properties of the substrate lesions. This
finding is similar to that found for other glycosylase-deleted mouse
strains, including the mOGG1 knock-out, which lacks glycosylase
activity against the major oxidized purine, 8-oxoguanine (6).
Although the reasons for the mild phenotype of the
glycosylase-deficient mice are still unclear, evidence is beginning to emerge that indicates that mammalian cells possess other enzymes, both
novel glycosylases and damage-specific endonucleases, that can remove
the damaged bases in the absence of the deleted enzymes, albeit at a
slower rate (7-10). These systems are in addition to alternative
mechanisms of repair such as nucleotide excision repair (11) and
transcription-coupled repair, which has been implicated in the repair
of both 8-oxoguanine and thymine glycol (12, 13). However, there is no
direct evidence indicating which repair system is utilized as a backup
mechanism in glycosylase knock-out mice.
Thus, in this study we have used cell-free extracts from our mNTH1
knock-out mice in combination with a sensitive DNA repair assay to
follow the removal of a unique 5,6-dihydrouracil adduct, one of the
major altered bases generated by ionizing radiation under anoxic
conditions (14), from closed circular substrate DNA. Our results
indicate that short-patch base excision repair is active in removing
the modified pyrimidine in extracts derived from both wild-type and
mNTH1 knock-out cells.
Materials--
Synthetic oligodeoxyribonucleotides purified by
high performance liquid chromatography were obtained from Midland
(8-oxoguanine) or Synthegen (5,6-dihydrouracil).
[ NTH1 Proteins--
Histidine-tagged human AP endonuclease 1 was purified on Ni2+-charged His-Bind Resin (Novagen,
Cambridge, MA) as recommended by the manufacturer.
DNA Substrates--
The oligonucleotides
5'-ATATACCGCG[8-oxo]GCCGATCAAGCTTATT-3' (30 pmol) and
5'-ATATACCGCGGCUGATCAAGCTTATT-3' (where U stands for
dihydrouracil, 30 pmol) were 5'-end-labeled with 100 µCi (33 pmol) of
[ BER Reactions--
The BER reactions were carried out as
described previously (17). In brief, the reaction mixture (50 µl) contained 50 mM Hepes-KOH, pH 7.8, 50 mM KCl, 10 mM MgCl2, 0.5 mM EDTA, 1.5 mM dithiothreitol, 2 mM ATP, 0.4 mg/ml bovine serum albumin, 25 mM phosphocreatine (di-Tris salt, Sigma), 2.5 µg of creatine
phosphokinase (type I, Sigma), 8.5% glycerol (Fluka), 20 µM each of the indicated dNTPs or ddNTPs, 50 ng (10 fmol)
of 32P-labeled single 8-oxoguanine or dihydrouracil
containing DNA substrate, and 400 ng of carrier plasmid DNA (pUC18).
Reactions were initiated by the addition of whole-cell extracts (100 µg) and incubated for the indicated time at 37 °C. The reactions
were stopped by addition of 2 µl of 0.5 M EDTA. Substrate
DNA was purified from the reaction mixture by phenol-chloroform
extraction and filtering through a Sepharose-G25 spin column
equilibrated with 10 mM Tris-HCl, pH 8.0. Filtrates were
spin-dried, dissolved in appropriate restriction buffers supplied by
the manufacturer, and treated with 10-40 units of the indicated
restriction endonuclease(s) for 1 h at 37 °C. An equal volume
of gel loading buffer was then added (95% formamide, 20 mM
EDTA, 0.02% bromphenol blue, and 0.02% xylene cyanol). Following
incubation at 90 °C for 2-5 min the reaction products were
separated by electrophoresis in a 10% polyacrylamide gel containing 7 M urea in 89 mM Tris-HCl, 89 mM
boric acid, and 2 mM EDTA, pH 8.0.
Cells and Extracts--
Whole-cell extracts were prepared from
frozen mouse testes by the method of Tanaka et al. (18) and
dialyzed overnight against buffer containing 25 mM
Hepes-KOH, pH 7.9, 2 mM dithiothreitol, 12 mM
MgCl2, 0.1 mM EDTA, 17% glycerol, and 0.1 M KCl. Extracts were aliquoted and stored at Repair of 8-Oxoguanine Is Efficient in mNTH1 Knock-out
Cells--
Two different cell extracts, prepared from testes collected
from normal or mNTH1 knock-out mice, were used in this study. To
demonstrate that these extracts are equally active in DNA repair of a
specific lesion other than dihydrouracil, we used closed circular
double-stranded DNA substrates bearing a single 8-oxoguanine/cytosine base pair at a defined position (Fig.
1A). The damage-containing strand of the substrate was 32P-labeled upstream of the
damage site. HindIII cleavage of the DNA substrates released
a 59-mer labeled fragment containing the damage (Fig. 1B,
lanes 1 and 2). This fragment has two
HaeIII restriction sites, but one of them is blocked by
8-oxoguanine (17), and thus simultaneous cleavage with
HaeIII and HindIII restriction endonucleases of
unrepaired substrate would generate a 52-mer labeled product containing
8-oxoguanine (unrepaired fragment). Following repair of the
8-oxoguanine-containing substrate the second HaeIII site
will be restored and should give rise to a 48-mer (repaired
fragment).
The 8-oxoguanine-containing substrate DNA was incubated with whole-cell
extract for 1 h, and after isolation from the reaction mixture it
was split into two equal aliquots. One-half of the sample was then
treated with HindIII, while the DNA in the other was
subjected to simultaneous cleavage with HindIII and
HaeIII. Thus, after HindIII cleavage we observed
only the release of a 59-mer labeled product (Fig. 1B,
lanes 1 and 2) and did not find accumulation of
any repair intermediates. However, simultaneous cleavage with
HindIII and HaeIII indicated that 85-90% of the 8-oxoguanine was efficiently repaired by both extracts (Fig.
1B, lanes 3 and 4,
48-mer).
Repair of Dihydrouracil by Normal and mNTH1 Knock-out Cell
Extracts--
As with the 8-oxoguanine-containing substrate, in the
dihydrouracil-containing substrate the HpaII restriction
site is blocked by dihydrouracil (17), and thus simultaneous cleavage
of unrepaired substrate DNA with HpaII and
HindIII restriction endonucleases generates only a 59-mer
labeled product containing dihydrouracil. However, once repair of the
dihydrouracil-containing substrate has taken place,
HindIII-HpaII cleavage will generate a 49-mer fragment (Fig. 2A).
Repair of the dihydrouracil-containing substrate by testes cell
extracts from normal mice was significantly slower than the repair of
8-oxoguanine, and preliminary experiments indicated that at least
3 h are required for processing of ~30% of the substrate (data
not shown). Thus, the dihydrouracil-containing substrate DNA was
incubated with testes cell extracts from normal or mNTH1 knock-out mice
for 3 h at 37 °C. Following recovery from the reaction mixture,
it was split into two equal aliquots, and one-half of the sample was
incubated with HindIII. As with 8-oxoguanine, we observed
only the release of a 59-mer labeled product (Fig. 2B, lanes 1 and 2) and did not find accumulation of
any repair intermediates. Simultaneous cleavage of the second half of
the sample with HindIII and HpaII indicated that
30-35% of dihydrouracil was repaired in normal cell extracts (Fig.
2B, lane 3). Surprisingly, we observed slow but
highly reproducible repair of dihydrouracil in DNA by cell extracts
prepared from mNTH1 knock-out mouse testes (Fig. 2B,
lane 4). Repair proceeded with about 20% efficiency
compared with the extract derived from normal mouse testes.
To eliminate the possibility that the observed 49-mer band representing
the repaired fraction is due to contamination of the substrate DNA with
AP sites or may have been generated by cleavage of unrepaired
substrate with HpaII, unrepaired substrate DNA was treated
with purified human AP endonuclease 1 (Fig.
3, lane 2) or with
HpaII (Fig. 3, lane 3) followed by
HindIII cleavage. Even after substantial overexposure of the
gels, we did not find any significant amount of 49-mer product. We thus
conclude that the 49-mer restriction product observed after incubation
with either cell extract indeed represented repaired substrate.
BER Is the Major Pathway for Dihydrouracil Repair in mNTH1
Knock-out Cell Extracts--
We have previously demonstrated that BER
is the major repair pathway for removal of oxidized pyrimidines (19).
However, in the absence of mNTH1, the major DNA glycosylase responsible for removal of dihydrouracil in DNA, there is a possibility for increased involvement of other repair systems, namely nucleotide excision repair (NER) (11, 20, 21) and nucleotide incision repair (7),
in processing of dihydrouracil. During NER, the damaged base is excised
as part of an oligonucleotide that includes 20-24 nucleotides 5' and
five to nine nucleotides 3' to the damaged site (22, 23). Since the
dihydrouracil-containing substrate was labeled 12 nucleotides 5' to the
damage, 25-30-mer labeled oligonucleotides should be generated as a
result of NER. However, we did not see 25-30-mer products even after
substantial overexposure of the gels (Fig. 3, lane 4).
The BER pathway proceeds mainly through a single-nucleotide replacement
mechanism (24). In contrast, the mechanism proposed for nucleotide
incision repair involves at least a two-nucleotide repair patch (7). To
evaluate the role of nucleotide incision repair in repair of
dihydrouracil in mNTH1 knock-out cell extracts we changed the repair
reaction conditions so that only short-patch repair was allowed (a
mixture of dCTP and ddGTP was used instead of all four dNTPs). Under
these conditions any extension of the repair gap beyond one nucleotide
will lead to incorporation of ddGMP (see Fig. 2A) and
termination of both DNA synthesis and ligation, detectable by
accumulation of incised, but unligated, products after
HindIII hydrolysis. As for human cell extracts (16, 25),
repair in wild-type mouse testes extracts was mostly accomplished
through insertion of a single nucleotide (Fig.
4, lane 3, 49-mer
product). Only a small amount proceeded via a synthesis of a repair
patch longer than one nucleotide (long-patch pathway), which results in
a repair block and accumulation of some 51-mer product after
HindIII or HindIII-HpaII cleavage
(Fig. 4, lanes 1 and 3). Similarly, repair in
mNTH1-deficient extracts was mostly accomplished through a
single-nucleotide BER pathway (Fig. 4, lane 4,
49-mer product).
The absence of any clearly discernable, detrimental phenotype in
our mNTH1 During the preparation of this article, two groups (8, 10) reported the
initial characterization of two novel bifunctional human DNA
glycosylases, NEH1/NEIL1 and NEH2/NEIL2, with homology to the E. coli MutM (Fpg) and Nei (endonuclease VIII) proteins. Based on the
limited information available to date, it is likely that NEIL1 is more
active on duplex oligonucleotides containing a single dihydrouracil,
although it is interesting to note that incubation of NEIL1 with
However, using extracts from a different mNTH1 From our results, the compensatory pathways are unlikely to be due to
NER or the recently described nucleotide incision repair pathway. We
found no evidence of NER incision products in our assays (Fig. 3),
while under polymerase blocking conditions, there was no reduction in
intensity of the 49-mer "repaired" band following incubation with
mNTH1 In conclusion, the availability of mammalian cell-free extracts lacking
mNTH1 has enabled us to identify a novel BER activity for the removal
of dihydrouracil. Recent results from our own laboratory (5) and others
(8-10) are revealing the presence of multiple, hitherto unknown, DNA
glycosylases and other damage-sensing enzymes. We are currently
continuing our studies to determine the nature of the glycosylase(s)
responsible for the repair activity described here to fully
characterize its mode of action and substrate specificities.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (3000 Ci/mmol) was purchased from
PerkinElmer Life Sciences.
/
Mice--
The generation and initial
characterization of our NTH1
/
mice will be described in detail
elsewhere; however, brief details are included here for clarity. The
mNth1 gene consists of 6 exons and is immediately
adjacent to the tuberous sclerosis 2 gene on chromosome 17 (2). Our
targeting vector consisted of a pgk-neo cassette inserted
between an Eco47III and ApaI site in exon 4, resulting in the deletion of 63 base pairs and disrupting the conserved
helix-hairpin-helix motif that is involved in substrate binding (15).
Homologous recombination in embryonic stem cells was confirmed
by long range PCR and Southern blotting, and correctly targeted cells
were microinjected into C57Bl/6J mouse blastocysts. NTH1
/
mice were obtained by crossing the NTH1+/
offspring of the resulting chimeras.
-32P]ATP and used for construction of substrates
containing single 8-oxoguanine or dihydrouracil in circular closed
double-stranded DNA as described previously (16).
80 °C.
All experiments were repeated at least three times, and representative
gels are shown.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Repair of 8-oxoguanine-containing substrate
by normal and mNTH1-deficient cell extracts. A, schematic
presentation of 8-oxoguanine-containing substrate. The sites of
cleavage by the restriction enzymes HindIII and
HaeIII and the position of the 32P label are
shown. The site of incision by AP endonuclease subsequent to
glycosylase processing of 8-oxoguanine (8-oxo) is indicated
with an arrow. B, repair of 8-oxoguanine by
whole-cell extracts. Reactions contained 50 ng of substrate DNA and 100 µg of whole-cell extract derived from normal (lanes 1 and
3) or mNTH1 knock-out mouse testes (lanes 2 and
4). Reactions were incubated at 37 °C for 1 h prior
to isolation of the substrate DNA followed by digestion with
HindIII (lanes 1 and 2) or
HindIII/HaeIII (lanes 3 and
4). Reaction products were analyzed by 10% denaturing
polyacrylamide gel electrophoresis.

View larger version (21K):
[in a new window]
Fig. 2.
Repair of dihydrouracil-containing substrate.
A, schematic presentation of dihydrouracil-containing
substrate. The sites of cleavage by the restriction enzymes
HindIII and HpaII and the position of the
32P label are shown. The site of incision by AP
endonuclease subsequent to glycosylase processing of dihydrouracil is
indicated with an arrow. DHU,
dihydrouracil. B, repair of dihydrouracil by testes
whole-cell extract. Reactions contained 50 ng of substrate DNA and 100 µg of whole-cell extract derived from normal mouse testes
(lanes 1 and 3) and from mNTH knock-out mouse
testes (lanes 2 and 4). Reactions were incubated
at 37 °C for 1 h prior to isolation of the substrate DNA
followed by digestion with HindIII (lanes 1 and
2) or HindIII/HpaII (lanes
3 and 4). Reaction products were analyzed by 10%
denaturing polyacrylamide gel electrophoresis.

View larger version (34K):
[in a new window]
Fig. 3.
Role of BER and NER in the repair of
dihydrouracil in mNTH1 knock-out extracts. Lane1, untreated
substrate was cleaved with HindIII; lane 2,
substrate DNA (50 ng) was treated with 2 ng of human AP endonuclease
and cleaved with HindIII; lane 3, untreated
substrate DNA was cleaved with HindIII/HpaII;
lane 4, substrate DNA (50 ng) was incubated with 100 µg of
whole-cell extract derived from mNTH1 knock-out mouse testes at
37 °C for 3 h prior to isolation of the substrate DNA followed
by digestion with HindIII. Reaction products were analyzed
by 10% denaturing polyacrylamide gel electrophoresis.

View larger version (57K):
[in a new window]
Fig. 4.
Repair of dihydrouracil under
single-nucleotide repair conditions. Reactions were carried out as
in Fig. 2 with the exception of the dNTPs being replaced with
dCTP/ddGTP. The reactions were incubated at 37 °C for 3 h with
100 µg of whole-cell extract derived from normal (lanes 1 and 3) or mNTH1 knock-out mouse testes (lanes 2 and 4). The substrate DNA was purified and then treated with
either HindIII alone (lanes 1 and 2)
or HindIII and HaeIII (lanes 3 and
4). Reaction products were analyzed by 10% denaturing
polyacrylamide gel electrophoresis.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice is highly suggestive of the action of one or more
compensatory repair pathways that remove potentially toxic pyrimidine
bases from damaged DNA. The results presented in this article indicate
that, for dihydrouracil at least, the principal method of repair in the
absence of mNTH1 is by one-nucleotide gap filling by the base excision
repair pathway. Extracts from mNTH1
/
mice were equally proficient
at directing the repair of 8-oxoguanine (Fig. 1) indicating that the
activity of 8-oxoganine-DNA glycosylase was unaffected by the deletion
of mNTH1 protein and that both extracts were capable of carrying out
the BER reaction. However as expected, differential repair of
dihydrouracil was observed when this DNA adduct was substituted for
8-oxoguanine. Nevertheless, although significantly reduced, repair of
this oxidized pyrimidine was observed when mNTH1
/
extracts were
used in the reaction.
-irradiated calf thymus DNA did not result in the release of
dihydrouracil (8). Therefore, it is possible that the initiation of the
BER activity observed in our assays is due to NEIL1 or NEIL2.
/
mouse strain, Takao
et al. (9) have recently described the partial
characterization of two novel thymine glycol-DNA glycosylases (TGG1 and
TGG2). These enzymes can be identified by their different reaction
mechanisms and are different again from the human NEI homologs. Thus,
while NEIL1 and NEIL2 posses a
/
-elimination activity, TGG1 is
most likely a monofunctional glycosylase unable to carry out strand incision, and TGG2 resembles E. coli endonuclease III (Nth)
in its mode of action, achieving strand nicking by
-elimination. Therefore, it will be interesting to learn whether the method by which
strand scission is achieved ultimately determines the mechanism of gap
filling. Further characterization of the substrate specificities of
these enzymes is required to determine whether dihydrouracil is also a
substrate for either of the TGG enzymes.
/
extracts, which is indicative of a single-base insertion
mechanism of BER (Fig. 4). This result effectively rules out incision
of the dihydrouracil by a damage-specific endonuclease, which would
give rise to a dangling nucleotide at the 5' terminus and repair
through the long-patch BER pathway (7).
| |
ACKNOWLEDGEMENTS |
|---|
Drs. S. L. Allinson and G. P. Margison are thanked for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by Cancer Research UK (to R. H. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 44-1235-824-563; Fax: 44-1235-834-776; E-mail: g.dianov@har.mrc.ac.uk.
Published, JBC Papers in Press, October 24, 2002, DOI 10.1074/jbc.M208153200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: BER, base excision repair; 8-oxoguanine, 8-oxo-7,8-dihydroguanine; dihydrouracil, 5,6-dihydrouracil; NER, nucleotide excision repair; mNTH1, murine thymine glycol-DNA glycosylase; dNTP, deoxyribonucleotide triphosphate; ddNTP, dideoxyribonucleotide triphosphate; AP, apurinic/apyrimidinic or abasic.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dizdaroglu, M. (1992) Mutat. Res. 275, 331-342[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Sarker, A. H., Ikeda, S., Nakano, H., Terato, H., Ide, H., Imai, K., Akiyama, K., Tsutsui, K., Bo, Z., Kubo, K., Yamamoto, K., Yasui, A., Yoshida, M. C., and Seki, S. (1998) J. Mol. Biol. 282, 761-774[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Aspinwall, R.,
Rothwell, D. G.,
Roldan-Arjona, T.,
Anselmino, C.,
Ward, C. J.,
Cheadle, J. P.,
Sampson, J. R.,
Lindahl, T.,
Harris, P. C.,
and Hickson, I. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
109-114 |
| 4. | Asagoshi, K., Odawara, H., Nakano, H., Miyano, T., Terato, H., Ohyama, Y., Seki, S., and Ide, H. (2000) Biochemistry 39, 11389-11398[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Elder, R. H., Parsons, J. L., and Hickson, I. D. (2002) Proc. Am. Assoc. Cancer Res. 43, Abstr. 4107 |
| 6. |
Klungland, A.,
Rosewell, I.,
Hollenbach, S.,
Larsen, E.,
Daly, G.,
Epe, B.,
Seeberg, E.,
Lindahl, T.,
and Barnes, D. E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13300-13305 |
| 7. | Ischenko, A. A., and Saparbaev, M. K. (2002) Nature 415, 183-187[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Hazra, T. K.,
Izumi, T.,
Boldogh, I.,
Imhoff, B.,
Kow, Y. W.,
Jaruga, P.,
Dizdaroglu, M.,
and Mitra, S.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
3523-3528 |
| 9. | Takao, M., Kanno, S.-i., Shiromoto, T., Hasegawa, R., Ide, H., Ikeda, S., Sarker, A. H., Seki, S., Xing, J. Z., Le, X. C., Weinfeld, M., Kobayashi, K., Miyazaki, J.-i., Muijtjens, M., Hoeijmakers, J. H. J., van der Horst, G., and Yasui, A. (2002) EMBO J. 21, 3486-3493[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Bandaru, V., Sunkara, S., Wallace, S. S., and Bond, J. P. (2002) DNA Repair 1, 517-529[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Reardon, J. T.,
Bessho, T.,
Kung, H. C.,
Bolton, P. H.,
and Sancar, A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9463-9468 |
| 12. | Le Page, F., Kwoh, E. E., Avrutskaya, A., Gentil, A., Leadon, S. A., Sarasin, A., and Cooper, P. K. (2000) Cell 101, 159-171[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Cooper, P. K.,
Nouspikel, T.,
Clarkson, S. G.,
and Leadon, S. A.
(1997)
Science
275,
990-993 |
| 14. | Furlong, E. A., Jorgensen, T. J., and Henner, W. D. (1986) Biochemistry 25, 4344-4349[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Thayer, M. M., Ahern, H., Xing, D., Cunningham, R. P., and Tainer, J. A. (1995) EMBO J. 14, 4108-4120[Medline] [Order article via Infotrieve] |
| 16. |
Dianov, G.,
Bischoff, C.,
Piotrowski, J.,
and Bohr, V. A.
(1998)
J. Biol. Chem.
273,
33811-33816 |
| 17. | Allinson, S. L., Dianova, I. I., and Dianov, G. L. (2001) EMBO J. 20, 6919-6926[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Tanaka, M., Lai, L. S., and Herr, W. (1992) Cell 68, 755-767[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Dianov, G. L.,
Thybo, T.,
Dianova, I. I.,
Lipinski, L. J.,
and Bohr, V. A.
(2000)
J. Biol. Chem.
275,
11809-11813 |
| 20. | Kow, Y. W., Wallace, S. S., and van Houten, B. (1990) Mutat. Res. 235, 147-156[Medline] [Order article via Infotrieve] |
| 21. | Lin, J.-J., and Sancar, A. (1989) Biochemistry 28, 7979-7984[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Wood, R. D.
(1997)
J. Biol. Chem.
272,
23465-23468 |
| 23. | Sancar, A. (1996) Annu. Rev. Biochem. 65, 43-81[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Dianov, G.,
Price, A.,
and Lindahl, T.
(1992)
Mol. Cell. Biol.
12,
1605-1612 |
| 25. |
Fortini, P.,
Parlanti, E.,
Sidorkina, O. M.,
Laval, J.,
and Dogliotti, E.
(1999)
J. Biol. Chem.
274,
15230-15236 |
This article has been cited by other articles:
![]() |
A. Das, T. K. Hazra, I. Boldogh, S. Mitra, and K. K. Bhakat Induction of the Human Oxidized Base-specific DNA Glycosylase NEIL1 by Reactive Oxygen Species J. Biol. Chem., October 21, 2005; 280(42): 35272 - 35280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Doublie, V. Bandaru, J. P. Bond, and S. S. Wallace The crystal structure of human endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for glycosylase activity PNAS, July 13, 2004; 101(28): 10284 - 10289. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miller, A. S. Fernandes, E. Zaika, M. M. McTigue, M. C. Torres, M. Wente, C. R. Iden, and A. P. Grollman Stereoselective excision of thymine glycol from oxidatively damaged DNA Nucleic Acids Res., January 15, 2004; 32(1): 338 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gros, A. A. Ishchenko, H. Ide, R. H. Elder, and M. K. Saparbaev The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway Nucleic Acids Res., January 2, 2004; 32(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karahalil, N. C. de Souza-Pinto, J. L. Parsons, R. H. Elder, and V. A. Bohr Compromised Incision of Oxidized Pyrimidines in Liver Mitochondria of Mice Deficient in NTH1 and OGG1 Glycosylases J. Biol. Chem., September 5, 2003; 278(36): 33701 - 33707. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |